4-Hydroxynonenal and TGF-β1 concur in inducing antiproliferative effects on the CaCo-2 human colon adenocarcinoma cell line

BioFactors

Volumn 24, Issue 1-4, 2005, Pages 237-246

  Vizio, Barbara ^a   Poli, Giuseppe ^a   Chiarpotto, Elena ^a   Biasi, Fiorella ^a,b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b CNR   (Italy)

^c SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

4 Hydroxynonenal; Apoptosis; Colon cancer; HNE; JNK; ROS; Smad; TGF

Indexed keywords

4 HYDROXYNONENAL; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SMAD PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN CACO 2; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; METASTASIS; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; UPREGULATION;

EID: 28644452530     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520240128     Document Type: Article

References (43)

1. F. Biasi, L. Tessitore, D. Zanetti, J.C. Cutrin, B. Zingaro, E. Chiarpotto, N. Zarkovic, G. Serviddio and G. Poli, Associated changes of lipid peroxidation and transforming growth factor β1 levels in human coloncancer during tumour progression, Gut 50 (2002), 361-367.
2. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem 72 (1976), 248-254.
3. S. Camandola, A. Scavazza, G. Leonarduzzi, F. Biasi, E. Chiarpotto, A. Azzi and G. Poli, Biogenic 4-hydroxy-2-nonenal activates transcription factor AP-1 but not NF-kappa B in cells of the macrophage lineage, Biofactors 6 (1997), 173-179.
4. S. Camandola, G. Poli and M.P. Mattson, The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons, J Neurochem 74 (2000), 159-168.
5. K.H. Cheeseman, Mechanisms and effects of lipid peroxidation, Mol Aspects Med 14 (1993), 191-197.
6. E. Chiarpotto, A. Scavazza, G. Leonarduzzi, S. Camandola, F. Biasi, P.M. Teggia, M. Garavoglia, A. Robecchi, A. Roncari and G. Poli, Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine, Free Radic Biol Med 22 (1997), 889-894.
7. R. Derynck, R.J. Akhurst and A. Balmain, TGF-beta signaling in tumor suppression and cancer progression, Nature Genet 29 (2001), 117-129.
8. M.U. Dianzani, Lipid peroxidation and cancer, Crit Rev Oncol/Hematol 15 (1993), 125-147.
9. W. Droge, Free radicals in the physiological control of cell function, Physiol Rev 82 (2002), 47-95.
10. H. Esterbauer, R.J. Schaur and H. Zollner, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radical Biol Med 11 (1991), 81-128.
11. R.A. Floyd, Antioxidants, oxidative stress, and degenerative neurological disorders, Proc Soc Exp Biol Med 222 (1999), 236-245.
12. C.C. Franklin, M.E. Rosenfeld-Franklin, C. White, T.J. Kavanagh and N. Fausto, TGFbeta1-induced suppression of glutathione antioxidant defenses in hepatocytes: caspase-dependent post-translational and caspase-independent transcriptional regulatory mechanisms, FASEB J 17 (2003), 1535-1537. Epub 2003 Jun 17.
13. J.P. Grande, Role of transforming growth factor-beta in tissue injury and repair, PSEBM 214 (1997), 27-40.
14. H. Hanafusa, J. Ninomiya-Tsuji, N. Masuyama, M. Nishita, J. Fujisawa, H. Shibuya, K. Matsumoto and E. Nishida, Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-β-induced gene expression, J Biol Chem 274 (1999), 27161-27167.
15. B. Herrera, M.M. Murillo, A. Alvarez-Barrientos, J. Beltran, M. Fernandez and I. Fabregat, Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-beta in fetal rat hepatocytes, Free Radic Biol Med 36 (2004), 16-26.
16. C. Ji, V. Amarnath, J.A. Pietenpol and L.J. Marnett, 4-Hydroxynonenal Induces Apoptosis via Caspase-3 Activation and Cytochrome c Release, Chem Res Toxicol 14 (2001), 1090-1096.
17. T. Kreuzer, R. Grube, A. Wutte, N. Zarkovic and R.J. Schaur, 4-Hydroxynonenal modifies the effects of serum growth factors on the expression of the c-fos proto-oncogene and the proliferation of HeLa carcinoma cells, Free Radic Biol Med 25 (1998), 42-49.
18. I. Kruman, A.J. Bruce-Keller, D. Bredesen, G. Waeg and M.P. Mattson, Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis, J Neurosci 17 (1997), 5089-5100.
19. G. Leonarduzzi, A. Scavazza, F. Biasi, E. Chiarpotto, S. Camandola, S. Vogel, R. Dargel and G. Poli, The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis, FASEB J 11 (1997), 851-857.
20. G. Leonarduzzi, M.C. Arkan, H. Basaga, E. Chiarpotto, A. Sevanian and G. Poli, Lipid oxidation products in cell signaling, Free Radic Biol Med 28 (2000), 1370-1378.
21. W. Liu, M. Kato, A.A. Akhand, A. Hayakawa, H. Suzuki, T. Miyata, K. Kurokawa, Y. Hotta, N. Ishikawa and I. Nakashima, 4-Hydroxynonenal induces a cellular redox statusrelated activation of the caspase cascade for apoptotic cell death, J Cell Sci 113 (2000), 635-641.
22. U.M. Marinari, M. Nitti, M.A. Pronzato and C. Domenicotti, Role of PKC-dependent pathways in HNE-induced cell protein transport and secretion, Mol Aspects Med 24 (2003), 205-211.
23. J. Massagué, How cells read TGF-beta signals, Nat Rev Mol Cell Biol 1 (2000), 169-178.
24. D. Maurice, C.E. Pierreux, M. Howell, R.E. Wilentz, M.J. Owen and C.S. Hill, Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability, J Biol Chem 276 (2001), 43175-43181.
25. M. Miyaki and T. Kurok, Smad4 (DPC4) inactivation in human cancer, Biochem Biophys Res Commun 306 (2003), 799-804.
26. G. Muzio, R.A. Salvo, A. Trombetta, R. Autelli, M. Maggiora, M. Terreno, M.U. Dianzani and R.A. Canuto, Dose-dependent inhibition of cell proliferation induced by lipid peroxidation products in rat hepatoma cells after enrichment with arachidonic acid, Lipids 34 (1999), 705-711.
27. A. Olaru, Y. Mori, J. Yin, S. Wang, M.C. Kimos, K. Perry, Y. Xu, F. Sato, F.M. Selaru, E. Deacu, A. Sterian, D. Shibata, J.M. Abraham and S.J. Meltzer, Loss of heterozygosity and mutational analyses of the ACTRII gene locus in human colorectal tumors, Lab Invest 83 (2003), 1867-1871.
28. C.W. Owens and R.V. Belcher, A colorimetric micro-method for the determination of glutathione, Biochem J 94 (1965), 705-711.
29. M. Parola, G. Robino, F. Marra, M. Pinzani, G. Bellomo, G. Leonarduzzi, P. Chiarugi, S. Camandola, G. Poli, G. Waeg, P. Gentilini and M.U. Dianzani, HNE interacts directly with JNK isoforms in human hepatic stellate cells, J Clin Invest 102 (1998), 1942-1950.
30. G. Poli and M. Parola, Oxidative damage and fibrogenesis, Free Radic Biol Med 22 (1997), 287-305.
31. G. Poli, Pathogenesis of liver fibrosis: role of oxidative stress, Mol Aspects Med 21 (2000), 49-98.
32. G. Poli and R.J. Schaur, 4-Hydroxynonenal in the pathomechanisms of oxidative stress, IUBMB Life 50 (2000), 315-321.
33. Y. Sano, J. Harada, S. Tashiro, R. Gotoh-Mandeville, T. Maekawa and S. Ishii, ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling, J Biol Chem 274 (1999), 8949-8957.
34. Y. Shi and J. Massagué, Mechanisms of TGF-beta signaling from cell membrane to the nucleus, Cell 113 (2003), 685-700.
35. N. Traverso, S. Menini, L. Cosso, P. Odetti, E. Albano, M.A. Pronzato and U.M. Marinari, Immunological evidence for increased oxidative stress in diabetic rats, Diabetologia 41 (1998), 265-270.
36. K. Uchida, M. Shiraishi, Y. Naito, Y. Torii, Y. Nakamura and T. Osawa, Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production, J Biol Chem 274 (1999), 2234-2242.
37. F. Verrecchia, L. Vindevoghel, R.J. Lechleider, J. Uitto, A.B. Roberts and A. Mauviel, Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner, Oncogene 20 (2001), 3332-3340.
38. Y.H. Wei and H.C. Lee, Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging, Exp Biol Med (Maywood) 227 (2002), 671-682.
39. M.P. Winesett, G.W. Ramsey and J.A. Barnard, Type II TGF(beta) receptor expression in intestinal cell lines and in the intestinal tract, Carcinogenesis 17 (1996), 989-995.
40. Y. Yang, R. Sharma, A. Sharma, S. Awasthi and Y.C. Awasthi, Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signalling, Acta Biochim Pol 50 (2003), 319-336.
41. A. Yoritaka, N. Hattori, K. Uchida, M. Tanaka, E.R. Stadtman and Y. Mizuno, Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease, Proc Natl Acad Sci USA 93 (1996), 2696-2701.
42. D. Zanetti, G. Poli, B. Vizio, B. Zingaro, E. Chiarpotto and F. Biasi, 4-hydroxynonenal and transforming growth factor-beta1 expression in colon cancer, Mol Aspects Med 24 (2003), 273-280.
43. N. Zarkovic, Z. Ilic, M. Jurin, R.J. Schaur, H. Puhl and H. Esterbauer, Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal, Cell Biochem Funct 11 (1993), 279-286.